It seems very logical that getting people to adopt healthy lifestyles–eat a good diet, get enough exercise, manage stress, avoid high-risk activities like smoking, drug use or too much alcohol intake–will both lower health spending and improve ultimate health outcomes. One expensive chronic condition is diabetes, which also can have an impact on the cardiovascular health of patients. Research reported in the New England Journal of Medicine suggests that an intensive lifestyle intervention for these patients did not improve cardiovascular outcomes. (NEJM Article) Analyzing over 5000 overweight patients with diabetes and following them for a very long period, a program of diet control and exercise was successful in producing greater weight loss, better glycemic control, better all-around fitness and better control of most cardiovascular risk factors, but was unsuccessful in reducing death from cardiovascular causes, nonfatal heart attacks, nonfatal stroke or hospitalizations for chest pain. The intervention patients also received significant counseling and support from providers. The loss of weight and the other improvements in health undoubtedly are important and almost certainly improve the quality of life for these patients. And the researchers did not compute economic outcomes, but you would suspect health utilization and spending was lower for the intervention group, perhaps enough to outweigh the cost of the intervention. It is unclear why rates of cardiovascular events were not different; perhaps more weight loss is needed or perhaps the control group had enough weight loss and health improvement to reduce their risks. But these interventions should not be abandoned just because they don’t appear to change some outcomes; they have other benefits that are worth pursuing.
Lifestyle Changes and Cardiovascular Outcomes for Patients with Diabetes
No Comments
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
The Anti-Strib, March 23, 2025
March 23, 2025
The Anti-Strib, March 23, 2025
An outrageous op-ed by our former health commissioner.
Commentary
More on Federal Government Departments
March 22, 2025
More on Federal Government Departments
A little more analysis and history on this very timely topic.
Commentary
The Anti-Strib, March 21 & 22
March 22, 2025
The Anti-Strib, March 21 & 22
Just another day of Trump bashing and Dem protecting by the Strib.